Vikas Mehta @drvikasmehta - Twitter Profile

over 3 years ago

BRONx-CAN Program Aims to Deliver the Best Cancer Treatments Early @BrendonStilesMD @drvikasmehta @ae_cancercenter #oncology https://t.co/xZBlkclK9M

0

1

0

Vikas Mehta @drvikasmehta

almost 4 years ago

@mcmullen_dr @duvvuri_md Tahoe!

0

1

0

drvikasmehta retweeted

Meryl Kravitz, MD @KravitzMeryl

almost 4 years ago

Proud to share this project about the relationship between bulbar poliomyelitis and tonsillectomy from @EinsteinMed & @Einstein_Oto

1

8

2

0

drvikasmehta retweeted

Einstein Otorhinolaryngology-Head and Neck Surgery @Einstein_Oto

almost 4 years ago

Our Monte Crew active on this Monday at academy! Pictured: Dr. Meryl Kravitz PGY-2, Dr. Christina Yang, Dr. Vikas Mehta #OTOMTG22

Einstein_Oto's tweet photo. Our Monte Crew active on this Monday at academy!
Pictured: Dr. Meryl Kravitz PGY-2, Dr. Christina Yang, Dr. Vikas Mehta
#OTOMTG22 https://t.co/xX2b8hAhvV

0

9

2

0

Who to follow

Dr Greg Farwell

@DrGregFarwell

Chair of Otorhinolaryngology-Head and Neck Surgery at University of Pennsylvania . Tweets are my own.

Neerav Goyal

@NGoyalMD

Otolaryngologist and Head and Neck Surgeon. Specializing in head and neck cancer, microvascular reconstruction, and skull base surgery.

baransumer

@HeadNeckSurgeon

drvikasmehta retweeted

Journal of the @NCCN @JNCCN

almost 4 years ago

𝙅𝙪𝙨𝙩 𝙋𝙪𝙗𝙡𝙞𝙨𝙝𝙚𝙙: @drvikasmehta and @RishaSheni propose instituting time to treatment initiation as a site-specific quality measure to improve oncologic outcomes, especially for disparate populations: https://t.co/QNdXaLUUTz #HealthDisparities #canceroutcomes

JNCCN's tweet photo. 𝙅𝙪𝙨𝙩 𝙋𝙪𝙗𝙡𝙞𝙨𝙝𝙚𝙙: @drvikasmehta and @RishaSheni propose instituting time to treatment initiation as a site-specific quality measure to improve oncologic outcomes, especially for disparate populations: https://t.co/QNdXaLUUTz #HealthDisparities #canceroutcomes https://t.co/JhIramEj0s

0

2

0

drvikasmehta retweeted

Balazs Halmos

@BalazsHalmosMD

over 4 years ago

Please note below publication on case fatality rate amongst a large cohort of pts w cancer dx (N=285) diagnosed w COVID-19 in NYC during Omicron wave as compared to large cohort of controls (10k+) assessing key associations as to age/co-morbid conditions/cancer type/tx etc.